Analysis of Somatic Mutations and Neoantigen Landscape from Liquid Biopsy-Derived cfDNA in Advanced Cancers

Dr Rodrigo Toledo
rtoledo@vhio.net

Request Access

Dataset ID	Description	Technology	Samples
EGAD50000001671	This study involves paired whole-exome sequencing (WES) of germline DNA and plasma-derived circulating cell-free DNA (cfDNA) from patients with advanced-stage cancers, aiming to identify somatic mutations and characterize potential neoantigens for immunotherapeutic targeting.	Illumina HiSeq 4000	138